Global DNA Fragment Synthesis Service Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global DNA Fragment Synthesis Service market size will reach US$ 3899 million by 2031.
DNA Fragment Synthesis Service is a biotechnology solution that enables the custom synthesis of DNA fragments based on user-defined sequences, using chemical synthesis and molecular cloning technologies. It is widely used in genetic engineering, synthetic biology, vaccine development, protein expression, and diagnostic assay design. The service offers double- or single-stranded DNA fragments ranging from a few dozen to several thousand base pairs, with options for standard sequences, custom features such as restriction sites or functional tags, and optimization for challenging sequences like high GC content or repeats. Compared to PCR-based methods, DNA synthesis provides superior accuracy, design flexibility, and shorter turnaround times. Synthesized DNA is typically sequence-verified and highly purified, and can be delivered as naked fragments or cloned into vectors. This service provides a powerful and scalable platform for building complex genetic constructs and engineered strains, supporting cutting-edge innovation in life science research and biotechnological applications.
United States market for DNA Fragment Synthesis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for DNA Fragment Synthesis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for DNA Fragment Synthesis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key DNA Fragment Synthesis Service players cover CD Genomics, GenScript, Eurofins Scientific, Base Gene, Tsingke, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “DNA Fragment Synthesis Service Industry Forecast” looks at past sales and reviews total world DNA Fragment Synthesis Service sales in 2024, providing a comprehensive analysis by region and market sector of projected DNA Fragment Synthesis Service sales for 2025 through 2031. With DNA Fragment Synthesis Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Fragment Synthesis Service industry.
This Insight Report provides a comprehensive analysis of the global DNA Fragment Synthesis Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on DNA Fragment Synthesis Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Fragment Synthesis Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Fragment Synthesis Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Fragment Synthesis Service.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Fragment Synthesis Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
DNA Short Fragment Service
DNA Long Fragment Service
Segmentation by Application:
Molecular Cloning
Gene Editing
Vaccine Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CD Genomics
GenScript
Eurofins Scientific
Base Gene
Tsingke
Geneviz
IDT
MCLAB
Synbio Technologies
NZYtech
Genetika Science Indonesia
Bio Basic
GenCefe
Please note: The report will take approximately 2 business days to prepare and deliver.
DNA Fragment Synthesis Service is a biotechnology solution that enables the custom synthesis of DNA fragments based on user-defined sequences, using chemical synthesis and molecular cloning technologies. It is widely used in genetic engineering, synthetic biology, vaccine development, protein expression, and diagnostic assay design. The service offers double- or single-stranded DNA fragments ranging from a few dozen to several thousand base pairs, with options for standard sequences, custom features such as restriction sites or functional tags, and optimization for challenging sequences like high GC content or repeats. Compared to PCR-based methods, DNA synthesis provides superior accuracy, design flexibility, and shorter turnaround times. Synthesized DNA is typically sequence-verified and highly purified, and can be delivered as naked fragments or cloned into vectors. This service provides a powerful and scalable platform for building complex genetic constructs and engineered strains, supporting cutting-edge innovation in life science research and biotechnological applications.
United States market for DNA Fragment Synthesis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for DNA Fragment Synthesis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for DNA Fragment Synthesis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key DNA Fragment Synthesis Service players cover CD Genomics, GenScript, Eurofins Scientific, Base Gene, Tsingke, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “DNA Fragment Synthesis Service Industry Forecast” looks at past sales and reviews total world DNA Fragment Synthesis Service sales in 2024, providing a comprehensive analysis by region and market sector of projected DNA Fragment Synthesis Service sales for 2025 through 2031. With DNA Fragment Synthesis Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Fragment Synthesis Service industry.
This Insight Report provides a comprehensive analysis of the global DNA Fragment Synthesis Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on DNA Fragment Synthesis Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Fragment Synthesis Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Fragment Synthesis Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Fragment Synthesis Service.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Fragment Synthesis Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
DNA Short Fragment Service
DNA Long Fragment Service
Segmentation by Application:
Molecular Cloning
Gene Editing
Vaccine Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CD Genomics
GenScript
Eurofins Scientific
Base Gene
Tsingke
Geneviz
IDT
MCLAB
Synbio Technologies
NZYtech
Genetika Science Indonesia
Bio Basic
GenCefe
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
111 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 DNA Fragment Synthesis Service Market Size by Player
- 4 DNA Fragment Synthesis Service by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global DNA Fragment Synthesis Service Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
